Skip to main content
. 2023 May 25;31:100468. doi: 10.1016/j.ensci.2023.100468

Table 2.

Meta-analysis results of secondary outcomes.

Outcomes Studies analyzed Effect size (95% CI) P-value I2
Length of Hospitalization 9 SMD: −0.45 (0.92–0.02) 0.06 91%
MV Duration 5 SMD: −0.54 (−1.67–0.59) 0.35 93%
Complications related to treatment 4 RR: 1.03 (0.71–1.48) 0.99 0%
Discontinuation 3 RR: 0.22 (0.06–0.88) 0.03 19%
Relapse 3 RR: 0.47 (0.20–1.14) 0.10 0%